European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Czechia — market report, May 2026

Oncology drug tenders in Czechia in May 2026: 108 tenders published (+19% month on month, +32% year on year), estimated at €76,990,362 in total, and 146 contracts awarded (-24% month on month, -16% year on year), worth €72,595,615 (awarded value). Buyers with the most tenders: Fakultní nemocnice Olomouc (17), Fakultní nemocnice Ostrava (7) and Institut klinické a experimentální medicíny (5); most contracts won: ROCHE s.r.o. (13), Janssen-Cilag s.r.o. (10) and Merck Sharp & Dohme s.r.o. (7). On average 4.8 bids per contract; 63% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
108
Contracts awarded
146
Contract value awarded
€72,595,615
Bids per contract
4.8
Tenders published per month
050100150May 25: 82May 25: 82May 25Jun 25: 86Jun 25: 86Jun 25Jul 25: 92Jul 25: 92Jul 25Aug 25: 96Aug 25: 96Aug 25Sep 25: 76Sep 25: 76Sep 25Oct 25: 118Oct 25: 118Oct 25Nov 25: 72Nov 25: 72Nov 25Dec 25: 84Dec 25: 84Dec 25Jan 26: 82Jan 26: 82Jan 26Feb 26: 103Feb 26: 103Feb 26Mar 26: 104Mar 26: 104Mar 26Apr 26: 91Apr 26: 91Apr 26May 26: 108May 26: 108108May 26
Contracts awarded per month
050100150200May 25: 174May 25: 174May 25Jun 25: 146Jun 25: 146Jun 25Jul 25: 125Jul 25: 125Jul 25Aug 25: 115Aug 25: 115Aug 25Sep 25: 128Sep 25: 128Sep 25Oct 25: 166Oct 25: 166Oct 25Nov 25: 143Nov 25: 143Nov 25Dec 25: 107Dec 25: 107Dec 25Jan 26: 89Jan 26: 89Jan 26Feb 26: 104Feb 26: 104Feb 26Mar 26: 111Mar 26: 111Mar 26Apr 26: 191Apr 26: 191Apr 26May 26: 146May 26: 146146May 26

The highlighted bar is May 2026. Hover a bar for its figure; the table below has every value.

FigureMay 2026April 2026ChangeMay 2025Change
Tenders published10891+19%82+32%
Estimated value€76,990,362€73,955,747+4%€119,437,632-36%
Buyers1110+10%8+38%
Contracts awarded146191-24%174-16%
Contract value (awarded)€72,595,615€122,059,124-41%€84,579,573-14%
Winners1413+8%12+17%
Bids per contract4.82.0—2.5—
Single-bid contracts63%76%—74%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 27
  • Olomoucký kraj 17
  • Královéhradecký kraj 9
  • Moravskoslezský kraj 8
  • Liberecký kraj 1

Procedures

  • not stated 46
  • Open procedure 36
  • Other procedure 26

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Czechia in May 2026?
108 (by 11 buyers); for comparison, April 2026: 91, May 2025: 82.
Who won the most oncology drug tenders in Czechia in May 2026?
By number of contracts: ROCHE s.r.o. (13), Janssen-Cilag s.r.o. (10), Merck Sharp & Dohme s.r.o. (7), Avenier a.s. (4) and Gilead Sciences s.r.o. (2); 14 companies won contracts in all.
Which buyers published the most oncology drug tenders in May 2026?
Fakultní nemocnice Olomouc (17), Fakultní nemocnice Ostrava (7), Institut klinické a experimentální medicíny (5), Oblastní nemocnice Mladá Boleslav, a.s., nemocnice Středočeského kraje (5) and Revmatologický ústav (3).
How competitive were oncology drug tenders in Czechia in May 2026?
On average 4.8 bids per contract (100 contracts with a known number of bids); 63% of contracts had a single bid.
What were the contracts worth in May 2026?
€72,595,615 (awarded value, 146 contracts); median about €690,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.